Nájera-Maldonado, L.;                     Parra-González, M.;                     Peralta-Cuevas, E.;                     Gutierrez-Onofre, A.J.;                     Garcia-Atutxa, I.;                     Villanueva-Flores, F.    
        Cracking the Blood–Brain Barrier Code: Rational Nanomaterial Design for Next-Generation Neurological Therapies. Pharmaceutics 2025, 17, 1169.
    https://doi.org/10.3390/pharmaceutics17091169
    AMA Style
    
                                Nájera-Maldonado L,                                 Parra-González M,                                 Peralta-Cuevas E,                                 Gutierrez-Onofre AJ,                                 Garcia-Atutxa I,                                 Villanueva-Flores F.        
                Cracking the Blood–Brain Barrier Code: Rational Nanomaterial Design for Next-Generation Neurological Therapies. Pharmaceutics. 2025; 17(9):1169.
        https://doi.org/10.3390/pharmaceutics17091169
    
    Chicago/Turabian Style
    
                                Nájera-Maldonado, Lucio,                                 Mariana Parra-González,                                 Esperanza Peralta-Cuevas,                                 Ashley J. Gutierrez-Onofre,                                 Igor Garcia-Atutxa,                                 and Francisca Villanueva-Flores.        
                2025. "Cracking the Blood–Brain Barrier Code: Rational Nanomaterial Design for Next-Generation Neurological Therapies" Pharmaceutics 17, no. 9: 1169.
        https://doi.org/10.3390/pharmaceutics17091169
    
    APA Style
    
                                Nájera-Maldonado, L.,                                 Parra-González, M.,                                 Peralta-Cuevas, E.,                                 Gutierrez-Onofre, A. J.,                                 Garcia-Atutxa, I.,                                 & Villanueva-Flores, F.        
        
        (2025). Cracking the Blood–Brain Barrier Code: Rational Nanomaterial Design for Next-Generation Neurological Therapies. Pharmaceutics, 17(9), 1169.
        https://doi.org/10.3390/pharmaceutics17091169